HKEX Stock Code: 01093English|繁體|简体

Highlight - 9M2022

Revenue
RMB23,496mn, +13.8%
Underlying profit attributable to shareholders
RMB4,624mn, +14.5%
Profit attributable to shareholders
RMB4,468mn, +3.1%
Basic earnings per share
RMB37.49 cents, +3.4%

Key Products

Finished drugs
Bulk drugs
© Copyright 2022 CSPC Pharmaceutical Group Limited. All Rights Reserved.